November 4, 2021 | Daily JAM, SGMO, Volatility |
Shares of Sangamo Therapeutics (SGMO) closed 19.15% higher today, November 4, on good news from multiple clinical trials at the gene therapy company.
December 10, 2020 | Daily JAM, Stock Alerts, Volatility |
Shares of gene therapy player Sangamo Therapeutics (SGMO) soared 52.98% in the regular session today, December 10, and tacked on another 3.77% in after-hours trading. I always try to understand a huge one-day move like that–and frankly I frequently fail. Here’s my take on Sangamo’s big move on Thursday.
July 9, 2019 | Daily JAM, SGMO, Stock Alerts, Volatility |
On July 5 Sangamo Therapeutics (SGMO) and partner Pfizer (PFE) announced update results of a Phase 1/2 study of Sangamo's SB-525 gene therapy for severe hemophilia A. The companies also announced that the U.S. Food & Drug Administration had granted regenerative...
April 2, 2019 | Daily JAM, SGMO, Stock Alerts |
Two big pieces of positive news popped shares of Sangamo Therapeutics (SGMO) today by 28.96% at the close. First, Sangamo announced interim data from its Hemophilia A program with Pfizer (PFE). The SB-525 gene therapy Phase 1/2 study in eight patients showed...
October 9, 2018 | Daily JAM, SGMO, Stock Alerts |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...